Silo pharma initiates toxicity study of its proprietary ketamine formulation for treatment of fibromyalgia

Studies of sp-26, the company's proprietary, time-released ketamine show positive results in reducing neuropathic nerve pain
SILO Ratings Summary
SILO Quant Ranking